Michael Kauffman Insider Trading $KPTI Karyopharm Therapeutics Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Michael Kauffman.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Michael Kauffman. Michael Kauffman is Director in INFINITY PHARMACEUTICALS, INC. ($INFI) and Director in EPIRUS Biopharmaceuticals, Inc. ($CRXX) and Chief Executive Officer in Karyopharm Therapeutics Inc. ($KPTI) and Director in Verastem, Inc. ($VSTM) and Director in Kezar Life Sciences, Inc. ($KZR).

Michael Kauffman in Karyopharm Therapeutics Inc.

Trading Symbol: KPTI
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Michael Kauffman: Chief Executive Officer
Holdings: 714,826 shares
Current Value: $7,377,004
Latest Transaction: Mar 23 2021
$KPTI Market Capitalization: $416.55M
$KPTI Previous Close: $10.32

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Michael Kauffman in Karyopharm Therapeutics Inc.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, CRXX, INFI, KPTI, KZR, VSTM

Page: 1 2 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Mar 23 2021	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Sell	S	12.39	4,000	49,553	714,826	718.8 K to 714.8 K (-0.56 %)
Mar 01 2021	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	A	14.56	153,500	2,234,960	153,500
Mar 01 2021	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	A	14.56	153,500	2,234,960	153,500
Mar 01 2021	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Grant	A	0.00	57,200	0	920,152	863 K to 920.2 K (+6.63 %)
Mar 01 2021	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Grant	A	0.00	57,200	0	718,826	661.6 K to 718.8 K (+8.65 %)
Feb 22 2021	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Sell	S	14.83	9,495	140,822	776,452	785.9 K to 776.5 K (-1.21 %)
Feb 22 2021	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Sell	S	14.83	9,495	140,822	575,126	584.6 K to 575.1 K (-1.62 %)
Feb 09 2021	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	M	0.00	14,300	0	42,900
Feb 09 2021	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	M	0.00	14,300	0	42,900
Feb 09 2021	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Buy	M	0.00	14,300	0	770,789	756.5 K to 770.8 K (+1.89 %)
Feb 09 2021	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Buy	M	0.00	14,300	0	569,422	555.1 K to 569.4 K (+2.58 %)
Oct 14 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	M	0.03	6,076	201	0
Oct 14 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	M	0.03	1,424	47	0
Oct 14 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Sell	S	14.89	7,500	111,683	756,489	764 K to 756.5 K (-0.98 %)
Oct 14 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Buy	M	0.03	6,076	201	763,989	757.9 K to 764 K (+0.80 %)
Oct 14 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Buy	M	0.03	1,424	47	757,913	756.5 K to 757.9 K (+0.19 %)
Oct 14 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	M	0.03	6,076	201	0
Oct 14 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	M	0.03	1,424	47	0
Oct 14 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Sell	S	14.89	7,500	111,683	756,489	764 K to 756.5 K (-0.98 %)
Oct 14 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Buy	M	0.03	6,076	201	763,989	757.9 K to 764 K (+0.80 %)
Oct 14 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Buy	M	0.03	1,424	47	757,913	756.5 K to 757.9 K (+0.19 %)
Aug 18 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	M	0.03	1,477	49	6,076
Aug 18 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Sell	S	15.00	1,477	22,155	756,489	758 K to 756.5 K (-0.19 %)
Aug 18 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Buy	M	0.03	1,477	49	757,966	756.5 K to 758 K (+0.20 %)
Jul 17 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	M	0.03	7,500	248	1,424
Jul 17 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Sell	S	19.43	7,500	145,723	756,489	764 K to 756.5 K (-0.98 %)
Jul 17 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Buy	M	0.03	7,500	248	763,989	756.5 K to 764 K (+0.99 %)
Jul 13 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	M	4.75	7,500	35,640	377,803
Jul 13 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	M	4.75	7,500	35,640	333,561
Jul 13 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Sell	S	19.53	7,500	146,487	756,489	764 K to 756.5 K (-0.98 %)
Jul 13 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Buy	M	4.75	7,500	35,640	763,989	756.5 K to 764 K (+0.99 %)
Jul 13 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Sell	S	19.71	300	5,912	555,122	555.4 K to 555.1 K (-0.05 %)
Jul 13 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Sell	S	18.98	7,200	136,627	555,422	562.6 K to 555.4 K (-1.28 %)
Jul 13 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Buy	M	4.75	7,500	35,640	562,622	555.1 K to 562.6 K (+1.35 %)
Jun 24 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	M	0.03	7,500	248	8,924
Jun 24 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Sell	S	20.00	7,500	150,000	756,489	764 K to 756.5 K (-0.98 %)
Jun 24 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Buy	M	0.03	7,500	248	763,989	756.5 K to 764 K (+0.99 %)
Jun 17 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	M	0.03	357	12	0
Jun 17 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	M	0.03	7,143	236	16,424
Jun 17 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Sell	S	16.20	357	5,783	756,489	756.8 K to 756.5 K (-0.05 %)
Jun 17 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Buy	M	0.03	357	12	756,846	756.5 K to 756.8 K (+0.05 %)
Jun 17 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Sell	S	16.38	7,143	116,996	756,489	763.6 K to 756.5 K (-0.94 %)
Jun 17 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Buy	M	0.03	7,143	236	763,632	756.5 K to 763.6 K (+0.94 %)
Jun 11 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	M	4.75	7,500	35,640	385,303
Jun 11 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	M	4.75	7,500	35,640	341,061
Jun 11 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Sell	S	18.50	7,500	138,746	756,489	764 K to 756.5 K (-0.98 %)
Jun 11 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Buy	M	4.75	7,500	35,640	763,989	756.5 K to 764 K (+0.99 %)
Jun 11 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Sell	S	18.13	7,500	135,944	555,122	562.6 K to 555.1 K (-1.33 %)
Jun 11 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Buy	M	4.75	7,500	35,640	562,622	555.1 K to 562.6 K (+1.35 %)
May 19 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	M	0.03	7,500	248	357
May 19 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	M	0.03	7,500	248	7,857
May 19 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Sell	S	20.00	7,500	150,000	756,489	764 K to 756.5 K (-0.98 %)
May 19 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Buy	M	0.03	7,500	248	763,989	756.5 K to 764 K (+0.99 %)
May 19 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Sell	S	18.65	7,500	139,841	756,489	764 K to 756.5 K (-0.98 %)
May 19 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Buy	M	0.03	7,500	248	763,989	756.5 K to 764 K (+0.99 %)
Apr 10 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	M	4.75	10,000	47,520	400,303
Apr 10 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	M	4.75	10,000	47,520	356,061
Apr 10 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Sell	S	18.61	10,000	186,115	756,489	766.5 K to 756.5 K (-1.30 %)
Apr 10 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Buy	M	4.75	10,000	47,520	766,489	756.5 K to 766.5 K (+1.32 %)
Apr 10 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Sell	S	20.64	10,000	206,404	555,122	565.1 K to 555.1 K (-1.77 %)
Apr 10 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Buy	M	4.75	10,000	47,520	565,122	555.1 K to 565.1 K (+1.80 %)
Mar 11 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	M	4.75	10,000	47,520	410,303
Mar 11 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	M	4.75	10,000	47,520	366,061
Mar 11 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Sell	S	22.38	3,000	67,141	756,489	759.5 K to 756.5 K (-0.40 %)
Mar 11 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Sell	S	22.58	7,000	158,054	759,489	766.5 K to 759.5 K (-0.91 %)
Mar 11 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Buy	M	4.75	10,000	47,520	766,489	756.5 K to 766.5 K (+1.32 %)
Mar 11 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Sell	S	22.64	2,068	46,821	555,122	557.2 K to 555.1 K (-0.37 %)
Mar 11 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Sell	S	22.11	7,932	175,365	557,190	565.1 K to 557.2 K (-1.40 %)
Mar 11 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Buy	M	4.75	10,000	47,520	565,122	555.1 K to 565.1 K (+1.80 %)
Feb 21 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Sell	S	16.48	8,817	145,321	756,489	765.3 K to 756.5 K (-1.15 %)
Feb 21 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Sell	S	16.48	8,817	145,321	555,122	563.9 K to 555.1 K (-1.56 %)
Feb 19 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	M	0.00	21,800	0	65,400
Feb 19 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	M	0.00	21,800	0	65,400
Feb 19 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Buy	M	0.00	21,800	0	765,306	743.5 K to 765.3 K (+2.93 %)
Feb 19 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Buy	M	0.00	21,800	0	563,939	542.1 K to 563.9 K (+4.02 %)
Feb 07 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	A	0.00	57,200	0	57,200
Feb 07 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	A	0.00	57,200	0	57,200
Feb 07 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	A	18.00	153,500	2,763,000	153,500
Feb 07 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	A	18.00	153,500	2,763,000	153,500
Jan 10 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	M	4.75	10,000	47,520	430,303
Jan 10 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	M	4.75	10,000	47,520	386,061
Jan 10 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Gift	G	0.00	17,313	0	0	17.3 K to 0 (-100.00 %)
Jan 10 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Gift	G	0.00	17,313	0	0	17.3 K to 0 (-100.00 %)
Jan 10 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Sell	S	18.57	10,000	185,705	743,506	753.5 K to 743.5 K (-1.33 %)
Jan 10 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Buy	M	4.75	10,000	47,520	753,506	743.5 K to 753.5 K (+1.34 %)
Jan 10 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Sell	S	19.19	10,000	191,880	542,139	552.1 K to 542.1 K (-1.81 %)
Jan 10 2020	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Buy	M	4.75	10,000	47,520	552,139	542.1 K to 552.1 K (+1.84 %)
Dec 11 2019	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	M	4.75	10,000	47,520	440,303
Dec 11 2019	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	M	4.75	10,000	47,520	396,061
Dec 11 2019	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Sell	S	17.02	10,000	170,210	731,134	741.1 K to 731.1 K (-1.35 %)
Dec 11 2019	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Buy	M	4.75	10,000	47,520	741,134	731.1 K to 741.1 K (+1.37 %)
Dec 11 2019	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Sell	S	15.99	10,000	159,896	529,767	539.8 K to 529.8 K (-1.85 %)
Dec 11 2019	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Buy	M	4.75	10,000	47,520	539,767	529.8 K to 539.8 K (+1.89 %)
Nov 12 2019	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	M	4.75	10,000	47,520	450,303
Nov 12 2019	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	M	4.75	10,000	47,520	406,061
Nov 12 2019	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Sell	S	14.63	10,000	146,254	731,134	741.1 K to 731.1 K (-1.35 %)
Nov 12 2019	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Buy	M	4.75	10,000	47,520	741,134	731.1 K to 741.1 K (+1.37 %)
Nov 12 2019	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Sell	S	14.76	10,000	147,610	529,767	539.8 K to 529.8 K (-1.85 %)
Nov 12 2019	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Buy	M	4.75	10,000	47,520	539,767	529.8 K to 539.8 K (+1.89 %)
Nov 05 2019	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	M	4.75	10,000	47,520	460,303
Nov 05 2019	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	M	4.75	10,000	47,520	416,061
Nov 05 2019	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Sell	S	12.00	10,000	120,000	731,134	741.1 K to 731.1 K (-1.35 %)
Nov 05 2019	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Buy	M	4.75	10,000	47,520	741,134	731.1 K to 741.1 K (+1.37 %)
Nov 05 2019	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Sell	S	12.00	10,000	120,000	529,767	539.8 K to 529.8 K (-1.85 %)
Nov 05 2019	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Buy	M	4.75	10,000	47,520	539,767	529.8 K to 539.8 K (+1.89 %)
Sep 17 2019	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	M	4.75	10,000	47,520	470,303
Sep 17 2019	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	M	4.75	10,000	47,520	426,061
Sep 17 2019	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Sell	S	12.00	10,000	120,000	731,134	741.1 K to 731.1 K (-1.35 %)
Sep 17 2019	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Buy	M	4.75	10,000	47,520	741,134	731.1 K to 741.1 K (+1.37 %)
Sep 17 2019	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Sell	S	12.00	10,000	120,000	529,767	539.8 K to 529.8 K (-1.85 %)
Sep 17 2019	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Buy	M	4.75	10,000	47,520	539,767	529.8 K to 539.8 K (+1.89 %)
Feb 19 2019	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	A	0.00	87,200	0	87,200
Feb 19 2019	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	A	0.00	87,200	0	87,200
Feb 19 2019	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	A	9.21	231,200	2,129,352	231,200
Feb 19 2019	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	A	9.21	231,200	2,129,352	231,200
Jan 09 2019	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	M	0.03	12,500	413	15,357
Jan 09 2019	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Sell	S	10.23	12,500	127,824	731,134	743.6 K to 731.1 K (-1.68 %)
Jan 09 2019	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Buy	M	0.03	12,500	413	743,634	731.1 K to 743.6 K (+1.71 %)
Dec 10 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	M	0.03	12,500	413	27,857
Dec 10 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Sell	S	10.11	12,500	126,423	713,510	726 K to 713.5 K (-1.72 %)
Dec 10 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Buy	M	0.03	12,500	413	726,010	713.5 K to 726 K (+1.75 %)
Nov 27 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	M	4.75	9,600	45,619	436,061
Nov 27 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Sell	S	11.00	9,600	105,600	512,143	521.7 K to 512.1 K (-1.84 %)
Nov 27 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Buy	M	4.75	9,600	45,619	521,743	512.1 K to 521.7 K (+1.87 %)
Nov 21 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	M	4.75	400	1,901	445,661
Nov 21 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Sell	S	11.14	400	4,455	512,143	512.5 K to 512.1 K (-0.08 %)
Nov 21 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Buy	M	4.75	400	1,901	512,543	512.1 K to 512.5 K (+0.08 %)
Nov 09 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	M	0.03	12,500	413	40,357
Nov 09 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Sell	S	11.65	12,500	145,593	713,510	726 K to 713.5 K (-1.72 %)
Nov 09 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Buy	M	0.03	12,500	413	726,010	713.5 K to 726 K (+1.75 %)
Oct 22 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	M	4.75	10,000	47,520	446,061
Oct 22 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Sell	S	12.63	10,000	126,304	512,143	522.1 K to 512.1 K (-1.92 %)
Oct 22 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Buy	M	4.75	10,000	47,520	522,143	512.1 K to 522.1 K (+1.95 %)
Oct 09 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	M	0.03	10,736	354	52,857
Oct 09 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	M	0.03	1,764	58	0
Oct 09 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Sell	S	16.13	6,000	96,767	713,510	719.5 K to 713.5 K (-0.83 %)
Oct 09 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Sell	S	15.39	6,500	100,066	719,510	726 K to 719.5 K (-0.90 %)
Oct 09 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Buy	M	0.03	10,736	354	726,010	715.3 K to 726 K (+1.50 %)
Oct 09 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Buy	M	0.03	1,764	58	715,274	713.5 K to 715.3 K (+0.25 %)
Sep 18 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	M	4.75	10,000	47,520	456,061
Sep 18 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Sell	S	18.26	10,000	182,615	512,143	522.1 K to 512.1 K (-1.92 %)
Sep 18 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Buy	M	4.75	10,000	47,520	522,143	512.1 K to 522.1 K (+1.95 %)
Sep 10 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	M	0.03	12,500	413	1,764
Sep 10 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Sell	S	19.31	12,500	241,384	713,510	726 K to 713.5 K (-1.72 %)
Sep 10 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Buy	M	0.03	12,500	413	726,010	713.5 K to 726 K (+1.75 %)
Aug 21 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	M	4.75	10,000	47,520	466,061
Aug 21 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Sell	S	17.46	10,000	174,568	512,143	522.1 K to 512.1 K (-1.92 %)
Aug 21 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Buy	M	4.75	10,000	47,520	522,143	512.1 K to 522.1 K (+1.95 %)
Aug 08 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	M	0.03	12,500	413	14,264
Aug 08 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Sell	S	18.04	12,500	225,556	713,510	726 K to 713.5 K (-1.72 %)

Page: 1 2 next >